drugset / Trial / NCT04856488

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

NCT04856488 ↗

Phase 3 Recruiting 182 enrolled Jan Calissendorff
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess if preoperative treatment with Lugol's solution prior to thyroidectomy can reduce the surgical complications hypoparathyroidism and laryngeal nerve palsy

Timeline

Start
2021-11-18
Primary completion
2028-08
Completion
2028-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodine-Potassium Iodide Unknown 5 % Oral

Indications